Is a complete ALLR research report available?

No complete published report is available for Allarity Therapeutics, Inc. (ALLR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · USD

$1.23

+0.07 (+6.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ALLR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	19.6M
Revenue (ttm)	345K
Net income (ttm)	-11.2M
EPS (ttm)	-$0.72
Shares out	15.9M
Volume	55,911.013
Beta	0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 345K
Net income (ttm): -11.2M
EPS (ttm): -$0.72
Market cap: 19.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ALLR indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001860657
Company name	Allarity Therapeutics, Inc.
Country	United States
Country code	US
Cusip	016744500
Employees	8
Employees Change	1%
Employees Change Percent	14.29
Enterprise value	$21.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0167445008
Last refreshed	2026-07-31
Market cap	$19.6M
Market cap category	Nano-Cap
Price	$1.23
Price currency	USD
Rev Per Employee	43,125x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	ALLR
Website	https://www.allarity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-57.48%
EV/Sales	61.61x
FCF yield	-85.33%
P/B ratio	2.81x
P/S ratio	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$345,000
Net Income	$-11.2M
Net Income Growth Years	1%
Pretax Margin	-3,260.58%
Profit Per Employee	$-1.4M
ROA	-23.7
Roa5y	-51.2
ROCE	-182.1
ROE	-87.92
ROIC	-31.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	16.05%
Cagr3y	-90.79%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$34.9M
Cash	$19.8M
Current Assets	$34.5M
Current Liabilities	$28M
Debt	$21.5M
Debt Equity	$3.11
Equity	$6.9M
Interest Coverage	-35.3
Liabilities	$28M
Long Term Assets	$420,000
Long Term Liabilities	$0
Net Cash	$-1.7M
Net Cash By Market Cap	$-8.6
Net Debt Equity	$0.24
Tangible Book Value	$6.9M
Tangible Book Value Per Share	$0.44
WACC	4.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.23
Net Working Capital	$8.2M
Quick ratio	0.75
Working Capital	$6.5M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-254.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	16.04%
200-day SMA	1.24
3Y total return	-99.92%
50-day SMA	1.38
50-day SMA vs 200-day SMA	50over200
All Time High	15,287,694.2
All Time High Change	-100%
All Time High Date	2021-12-21
All Time Low	0.61
All Time Low Change	100.39%
All Time Low Date	2025-04-09
ATR	0.09
Beta	0.53
Beta1y	0.91
Beta2y	0.79
Ch YTD	13.89
High	1.24
High52	2.35
High52 Date	2025-08-26
High52ch	-47.66%
Low	1.17
Low52	0.77
Low52 Date	2026-02-03
Low52ch	60.01%
Ma50ch	-11%
Price vs 200-day SMA	-0.4%
RSI	48.48
RSI Monthly	9.82
RSI Weekly	27.92
Sharpe ratio	0.56x
Sortino ratio	1.1
Total Return	-254.81%
Tr YTD	13.89
Tr1m	-5.38%
Tr1w	0.82%
Tr3m	-10.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.25
Operating Income	$-12.3M
Operating margin	-3,552.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,610,451%
Float Percent	98.11%
Net Borrowing	20,000,000
Shares Insiders	1.89%
Shares Institutions	5.97%
Shares Out	15,910,724
Shares Qo Q	0.02%
Shares Yo Y	254.81%
Short Float	0.93%
Short Ratio	1.05
Short Shares	0.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.4M
Adjusted OCF	-17,330,000
Average Volume	95,706.8x
Bv Per Share	0.44
CAPEX	$-72,000
Ch1m	-5.38
Ch1w	0.82
Ch1y	16.04
Ch3m	-10.87
Ch3y	-99.92
Ch6m	17.7
Change	6.03%
Change From Open	2.93
Close	1.16
Days Gap	3.02
Depreciation Amortization	-50,000
Dollar Volume	68,770.5
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-12.6M
EBITDA	$-12.7M
EPS	$-0.72
F Score	0
FCF	$-16.7M
FCF EV Yield	-78.57x
FCF Per Share	$-1.05
Financing CF	19,245,000
Fiscal Year End	December
Founded	2,004
Investing CF	-72,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-09-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	1.23
Ma150ch	-0.32%
Ma20	1.19
Ma20ch	3.02%
Net CF	2,108,000
Next Earnings Date	2026-08-14
Open	1.2
Optionable	No
Position In Range	85.71
Post Close	1.23
Postmarket Change Percent	0.81
Postmarket Price	$1.24
Ppne	420,000
Price Date	2026-07-30
Ptbv Ratio	2.83
Relative Volume	0.58x
Revenue	345,000x
SBC By Revenue	203.77x
Share Based Comp	703,000
Tr6m	17.7%
Us State	Florida
Volume	55,911
Z Score	-5.88

Allarity Therapeutics, Inc. (ALLR)

Coverage state: Market snapshot only — no published research

Generate the first ALLR analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ALLR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALLR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ALLR

Frequently asked questions